| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/21/2008 | CN101182550A Flavonoids from phellinus, method of producing the same and use |
| 05/21/2008 | CN101182548A 1 typerecombinant adeno related viral vaccine of HPV16 and method of producing the same |
| 05/21/2008 | CN101182517A Multi-target point cocktail double strand small interfere RNA used for curing disease and method of producing same |
| 05/21/2008 | CN101182493A Transgenic mesenchyma stem cell for curing radiation enteritis and method of producing the same |
| 05/21/2008 | CN101182355A Antibacterial peptide fusion protein gene, recombinant carrier thereof, transformant and expression product thereof |
| 05/21/2008 | CN101182349A Recombinant octreotide and uses thereof |
| 05/21/2008 | CN101182332A Manganese complexes having antitumor and affecting mitochondria functions |
| 05/21/2008 | CN101182321A Indolizine heterocyclic nitrogen naphthoquinone derivatives as well as preparation method and anticancer use thereof |
| 05/21/2008 | CN101182315A Substituted benzamido methyl formate compound as well as preparation method and uses thereof |
| 05/21/2008 | CN101182309A Targeted leading compounds having latent anticancer actives |
| 05/21/2008 | CN101181634A Application of proline isomerase in the preparation of antineoplastic medicament |
| 05/21/2008 | CN101181628A Application of human affinity prime in the preparation of anti-cancer medicament |
| 05/21/2008 | CN101181627A Application of human affinity prime in the preparation of resistance liver cancer medicament |
| 05/21/2008 | CN101181609A Externally used antitumor chinese herbal medicine |
| 05/21/2008 | CN101181591A Capsule coordination for resisting bone tumor and manufacturing method |
| 05/21/2008 | CN101181584A Chinese medicine prescription orally taken for curing leukocytopenia |
| 05/21/2008 | CN101181573A Medicine for curing tumor and preparation method thereof |
| 05/21/2008 | CN101181571A Traditional Chinese medicine for curing cancer |
| 05/21/2008 | CN101181564A Chinese medicine compound preparations with antineoplastic activity |
| 05/21/2008 | CN101181529A Chinese medicine composition for curing tumor and preparation method thereof |
| 05/21/2008 | CN101181516A Chinese medicine prescription orally taken for curing leukaemia |
| 05/21/2008 | CN101181478A Chinese medicine for curing lung cancer and mammary cancer |
| 05/21/2008 | CN101181473A Compound maytenfolic splinter |
| 05/21/2008 | CN101181440A Chinese medicine composition for curing hemopathy as well as preparation method and usage thereof |
| 05/21/2008 | CN101181412A Chinese medicine prescription orally taken for curing leukocytopenia |
| 05/21/2008 | CN101181391A Chinese medicine composition for curing uterine cancer and cervical cancer |
| 05/21/2008 | CN101181342A Pharmaceutical combination with resisting liver cancer activity |
| 05/21/2008 | CN101181339A Mass control method of aidi injection preparations |
| 05/21/2008 | CN101181337A High ester catechin capsule for curing mammary cancer and preparation method thereof |
| 05/21/2008 | CN101181321A Effective component of angelica as well as preparation method and application |
| 05/21/2008 | CN101181315A New purpose of Yulangsan polysaccharide |
| 05/21/2008 | CN101181311A Spirulina composition as well as preparation method and application thereof |
| 05/21/2008 | CN101181307A Proprietary Chinese medicine for curing mastadenitis and breast cancer as well as preparing method |
| 05/21/2008 | CN101181293A Oral health lozenge for preventing tooth decay |
| 05/21/2008 | CN101181291A Tea polyoses injection |
| 05/21/2008 | CN101181280A Pirarubicin freeze-dry preparations and preparation method thereof |
| 05/21/2008 | CN101181273A Method for preparing chitosan-polyasparagic acid-5efudix nano particle |
| 05/21/2008 | CN101181272A Compositions and uses of et743 for treating cancer |
| 05/21/2008 | CN101181269A Methods of treating cancer using an fpt inhibitor and antineoplastic agents |
| 05/21/2008 | CN101181268A Sensitization tumour cell medicament and uses thereof |
| 05/21/2008 | CN101181263A Treatment of respiratory diseases |
| 05/21/2008 | CN101181260A Rabdosia nail element clathrate and pharmaceutical preparation containing the same |
| 05/21/2008 | CN101181235A Tantudinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181234A Literdinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181233A Gefitinib sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181232A Marseilledinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181231A Sustained-release implantation agent of urotrotiken |
| 05/21/2008 | CN101181230A Estramustine sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181229A Busulfan sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181225A System for transferring nanometer polyalcohol micelle medicament and preparing method as well as application thereof |
| 05/21/2008 | CN100389203C Fermentation substrate of antitumour compound interseat shell lactone |
| 05/21/2008 | CN100389202C Fermentation substrate of antitumour compound fungus epoxydiester |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389190C Antrodia mycelium active substance preparation method and its compositions |
| 05/21/2008 | CN100389128C Fusion protein of single antibody-interleukin 2, its preparation and use |
| 05/21/2008 | CN100389126C Endothelial cell proliferation inhibitor and method of use |
| 05/21/2008 | CN100389125C Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use |
| 05/21/2008 | CN100389119C (trans)-2-deoxy-2-(fluoromethano)-4-R acyl-cytidine compound, preparation process and use thereof |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100389105C Substituted benzal cyclopentanone derivatives and their use |
| 05/21/2008 | CN100388942C Leukemia treating Chinese medicine composition and its preparation method |
| 05/21/2008 | CN100388941C Medicine for regulating incretion, promoting immunity, promoting tumor cell apoptosis and its preparation method |
| 05/21/2008 | CN100388925C Medication composition of replenishing qi to invigorate the spleen, preparation method and usage |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375199 Cancer-associated genes |
| 05/20/2008 | US7375186 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375135 Fatty acid derivatives; preparation and uses thereof |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375105 Neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine, cardiac hypertrophy |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes |
| 05/20/2008 | US7375094 Produced via Streptomyces; antitumor agents; time-release agents; for opiod-resistant pain; drug screening |
| 05/20/2008 | US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 05/20/2008 | US7374756 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis |
| 05/20/2008 | US7374752 Reovirus for the treatment of cellular proliferative disorders |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2420881C Process for selectively extracting bioactive components |
| 05/20/2008 | CA2416976C Treatment of estrogen receptor positive carcinoma with a rapamycin and an antiestrogen |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/20/2008 | CA2322862C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/20/2008 | CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 05/20/2008 | CA2219819C Novel compounds, the preparation and use thereof |
| 05/20/2008 | CA2219818C Novel compounds, the preparation and use thereof |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/15/2008 | WO2008058287A1 COMBINATION OF ERα+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER |
| 05/15/2008 | WO2008058229A1 Pyridinone compounds |
| 05/15/2008 | WO2008058225A2 Methods and compositions for treating cancer using bcl-2 antisense oligomers, tyrosine kinase inhibitors, and chemotherapeutic agents |
| 05/15/2008 | WO2008058126A2 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |